Shortening Medication Regimens with Pro-Healing Coatings One of the primary goals of vascular research in 2025 is to reduce the amount of time patients need to spend on heavy blood-thinning medications, known as dual antiplatelet therapy. While these drugs prevent clots, they also increase the risk of bleeding complications. New devices featuring "bio-active" surfaces are now being utilized to...